Short-and long-term outcomes of pneumonectomy for non-small cell lung cancer
Zhiping Wei, Haitao Huang, Jun Yao
Abstract
Zhiping Wei, Haitao Huang, Jun Yao
Abstract
Objective To assess the mortality, complications and major morbidity of pneumonectomy for non-small cell lung cancer(NSCLC) and to establish the importance of various prognostic factors. Methods The data of 64 consecutive patients who underwent pneumonectomy for NSCLC were retrospectively reviewed. Results The 30-day mortality rate was 7.8%(5/64). Complications developed in 29.7%(19/64) and overall 5-year survival was 19.0%.Pathological stage Ⅲ(P=0.030) and right pneumonectomy(P=0.010) were independent risk factors of an adverse outcome.Survival was not significantly influenced by histological types (P=0.125) or curability (P=0.587). Conclusion Pneumonectomy is associated with acceptable overall morbidity and mortality.However, the patients with pathological stage Ⅲ or right pneumonectomy require special consideration.Pneumonectomy should be performed only in selected patients. Key words: Pneumonectomy; Carcinoma, non-small-cell lung; Survival rate
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective To assess the mortality, complications and major morbidity of pneumonectomy for non-small cell lung cancer(NSCLC) and to establish the importance of various prognostic factors. Methods The data of 64 consecutive patients who underwent pneumonectomy for NSCLC were retrospectively reviewed. Results The 30-day mortality rate was 7.8%(5/64). Complications developed in 29.7%(19/64) and overall 5-year survival was 19.0%.Pathological stage Ⅲ(P=0.030) and right pneumonectomy(P=0.010) were independent risk factors of an adverse outcome.Survival was not significantly influenced by histological types (P=0.125) or curability (P=0.587). Conclusion Pneumonectomy is associated with acceptable overall morbidity and mortality.However, the patients with pathological stage Ⅲ or right pneumonectomy require special consideration.Pneumonectomy should be performed only in selected patients. Key words: Pneumonectomy; Carcinoma, non-small-cell lung; Survival rate
Key concepts: Pneumonectomy, Medicine, Lung cancer, Pathological, Surgery, Stage (stratigraphy), Lung, Survival rate